age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
78.89697
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 11
|
under $11k
| 0
| 21,818
| 12,756.3516
| 13,824
| 13
|
white
| 15.599609
| 16
| 0.86792
| 0.781982
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 66
| 7
| 110
| 32
| 36.69531
| 226.0625
| 3.199707
| null | 0.5
| 138
| 7.379883
| 260
| 8
| 4,525
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 670
| 0
|
40.80798
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 60,445
| 34,727.7812
| 36,611
| 53
|
white
| 26.699219
| 44
| 0.834961
| 0.777954
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 122
| 9.798828
| 55
| 14
| 39.5
| 151.40625
| 3
| 1.199951
| 0.799927
| 140
| 7.5
| 291
| 13
| 2,505
| null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
72.02997
|
male
| 1
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 3
|
under $11k
| 0
| 109,406
| 66,974.1875
| 64,869
| 40.75
|
black
| 39.59375
| 86
| 0.417969
| 0.29895
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 28
| 63
| 11
| 74
| 42
| 38.59375
| 374.9375
| 2.5
| 0.299988
| 4.699219
| 145
| 7.40918
| 87
| 113
| 847
| null | 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
60.90298
|
male
| 0
| 76
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
$11-$25k
| 0
| 275,754
| 160,613.25
| 191,746
| 42
|
white
| 29.597656
| 48
| 0.623901
| 0.519897
| 4
| 0
| 0
|
yes
| null | null |
no dnr
| 76
| 103
| 10.099609
| 55
| 10
| 35.39844
| null | null | 0.899902
| 0.799927
| 136
| null | 152
| 14
| null | null | 0
| null | 0
| 253
| 1
|
46.38998
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 41
| 60,434
| 35,845.125
| 34,689
| 31
|
black
| 28.097656
| 46
| 0.687988
| 0.595947
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 19
| 108
| 8.699219
| 110
| 36
| 36.19531
| 55
| null | 11
| 1.199951
| 148
| 7.479492
| 93
| 31
| 6,590
| null | 6
|
SIP>=30
| 6
| 667
| 0
|
75.034
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 7
|
under $11k
| 0
| 33,122
| 21,182.2344
| 22,587
| 15.666664
|
white
| 21.898438
| 39
| 0.803955
| 0.738892
| 1
| 0
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 16
| 62
| 5.199219
| 130
| 52
| 32.09375
| 144
| 2.699707
| 5.899414
| 1.699951
| 137
| 7.369141
| 42
| 74
| 1,145
| null | 1
|
no(M2 and SIP pres)
| 1
| 668
| 0
|
63.17297
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 10,983
| 6,165.0703
| 4,119
| 16
|
white
| 7.199219
| 9
| 0.914917
| 0.80188
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 6
| 105
| 19.398438
| 75
| 28
| 36
| 170
| null | 0.799927
| 1.399902
| 148
| 7.40918
| 283
| 64
| 1,470
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 375
| 1
|
65.89697
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 7
|
under $11k
| 9
| 58,303
| 34,019
| 31,352
| 33
|
white
| 34.09375
| 68
| 0.472961
| 0.353943
| 10
| 1
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 5
| 107
| 5.199219
| 108
| 20
| 36.5
| 257.125
| 3.799805
| 0.5
| 1.199951
| 128
| 7.469727
| 105
| 33
| 1,025
| null | 6
|
<2 mo. follow-up
| 6
| 5
| 1
|
74.81494
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 8
|
under $11k
| 0
| 8,861
| 4,987.0117
| 3,160
| 12
|
white
| 13.5
| 9
| 0.843994
| 0.656982
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 6
| 73
| 4.799805
| 75
| 20
| 36.29688
| 257.125
| 3.399902
| 0.399963
| 1.099854
| 138
| 7.429688
| 99
| 13
| 2,225
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 347
| 1
|
60.41599
|
female
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 9
| 105,918
| 66,441.9375
| 62,850
| 29
|
white
| 27.796875
| 32
| 0.737915
| 0.655884
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 37
| 127
| 15.099609
| 125
| 32
| 38.39844
| 204.0625
| null | null | 1.299805
| 145
| 7.459961
| 191
| 19
| 900
| null | 7
|
no(M2 and SIP pres)
| 7
| 665
| 0
|
55.84399
|
male
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 5
|
under $11k
| 9
| 40,892
| 27,040.8281
| 25,830
| 12.5
|
black
| 19.097656
| 46
| 0.862915
| 0.814941
| 2
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 27
| 100
| 8.398438
| 72
| 32
| 38.39844
| 292
| 3.299805
| 0.399963
| 0.899902
| 133
| 7.469727
| 93
| 23
| null | 0
| null | null | 0.494751
| 665
| 0
|
43.05798
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 9,909
| 5,033.582
| 3,959
| 12
|
white
| 20.398438
| 14
| 0.692993
| 0.401978
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 4
| 105
| 11.898438
| 55
| 12
| 36.79688
| 118.45312
| 3.199707
| 0.599976
| 0.899902
| 142
| 7.449219
| 133
| 30
| 3,840
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 250
| 1
|
55.26099
|
male
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 24,646
| 14,752.6719
| 12,783
| 21.5
|
white
| 22.296875
| 38
| 0.684937
| 0.591919
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.1
|
dnr after sadm
| 6
| 58
| 18.796875
| 55
| 24
| 38.29688
| 169.375
| 1.599854
| 0.399963
| 1
| 131
| 7.369141
| 177
| 21
| 1,520
| null | 6
|
<2 mo. follow-up
| 6
| 7
| 1
|
57.06998
|
male
| 1
| 35
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
>$50k
| 41
| 157,909
| 92,457.75
| 87,630
| 43.75
|
white
| 33.796875
| 56
| 0.089996
| 0.035995
| 14
| 0
| 0
|
metastatic
| 0.4
| 0.2
|
dnr after sadm
| 16
| 70
| 14.599609
| 96
| 22
| 35.59375
| 252.15625
| null | null | 0.799927
| 125
| 7.419922
| 209
| 11
| 2,100
| null | 0
|
<2 mo. follow-up
| 0
| 35
| 1
|
60.32898
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 24
| null | 0
| 49,023
| 29,819.8281
| 30,906
| 29.666656
|
white
| 35.296875
| 41
| 0.612915
| 0.506958
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 15
| 113
| 3.699707
| 100
| 12
| 36.59375
| null | 2.899902
| null | 0.899902
| 134
| null | 209
| 9
| 2,970
| null | 0
|
no(M2 and SIP pres)
| 0
| 663
| 0
|
75.32098
|
female
| 1
| 19
|
Coma
|
Coma
| 2
| null |
under $11k
| 41
| 71,949
| null | null | 33.666657
|
black
| 21
| 30
| 0.490967
| 0.418945
| 1
| 0
| 0
|
no
| 0.8
| 0.75
|
dnr after sadm
| 12
| 113
| 7
| 80
| 20
| 38.19531
| null | 2.799805
| 1.199951
| 1.199951
| 134
| null | 117
| 28
| 900
| null | 2
|
<2 mo. follow-up
| 2
| 19
| 1
|
66.935
|
male
| 0
| 38
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 9
| 70,401
| 42,746.9688
| 42,579
| 17.25
|
white
| 26.796875
| 54
| 0.415955
| 0.296997
| 10
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
dnr after sadm
| 12
| 77
| 3.599609
| 75
| 24
| 35.59375
| 360
| 3.199707
| 2.199707
| 3.799805
| 135
| 7.369141
| 161
| 101
| 780
| null | null | null | 3.121582
| 200
| 1
|
53.577
|
female
| 0
| 58
|
Coma
|
Coma
| 4
| 12
| null | 37
| 123,391
| 72,837.125
| 80,034
| 26
|
black
| 21.398438
| 26
| 0.599976
| 0.535889
| 14
| 1
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 58
| 118
| 12.699219
| 125
| 24
| 36.89844
| 203.3125
| null | 0.5
| 0.599976
| 138
| 7.459961
| 203
| 37
| 2,535
| null | 4
|
adl>=4 (>=5 if sur)
| 4
| 661
| 0
|
64.86798
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 8,329
| 5,168.0312
| 4,771
| 7
|
white
| 16
| 17
| 0.875
| 0.792969
| 1
| 1
| 0
|
yes
| null | null |
no dnr
| 4
| 75
| 24.5
| 80
| 24
| 38
| 293.3125
| 2.5
| 0.799927
| 1.699951
| 133
| 7.379883
| 10
| 192
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 140
| 1
|
78.54596
|
female
| 1
| 7
|
Coma
|
Coma
| 2
| 8
|
under $11k
| 61
| 32,912
| null | null | 26.5
|
black
| 40.59375
| 63
| 0
| 0
| 12
| 1
| 0
|
yes
| 0.01
| 0
|
dnr after sadm
| 5
| 118
| 19
| 125
| 46
| 38.79688
| 240
| null | 1.199951
| 0.5
| 143
| 7.429688
| 212
| 3
| 4,445
| null | 6
|
<2 mo. follow-up
| 6
| 7
| 1
|
66.57098
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 100
| 61,060
| 35,093.3125
| 36,950
| 41
|
white
| 28
| 61
| 0.201996
| 0.108994
| 6
| 1
| 0
|
no
| 0
| 0
|
dnr after sadm
| 4
| 103
| 7.399414
| 85
| 22
| 36.89844
| null | null | 0.399963
| 1.299805
| 140
| null | 95
| 24
| null | null | null |
<2 mo. follow-up
| 3.190918
| 6
| 1
|
49.52798
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
under $11k
| 0
| 66,030
| 37,520.5625
| 38,252
| 32
|
white
| 23.5
| 27
| 0.829956
| 0.771973
| 5
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 11
| 78
| 12.699219
| 115
| 42
| 38.69531
| 236.65625
| 3
| 3.899902
| 3.299805
| 148
| 7.419922
| 174
| 96
| 1,000
| null | 0
|
no(M2 and SIP pres)
| 0
| 659
| 0
|
70.32196
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 4
|
under $11k
| 0
| 53,749
| 29,518.1562
| 27,179
| 29.666656
|
white
| 53
| 78
| 0.017998
| 0.004
| 6
| 1
| 0
|
yes
| 0.5
| 0.2
|
no dnr
| 15
| 30
| 7.799805
| 135
| 33
| 40.59375
| 305
| null | null | 5.799805
| 144
| 7.319336
| 90
| 54
| 140
| null | 0
|
no(M2 and SIP pres)
| 0
| 467
| 1
|
34.168
|
female
| 1
| 41
|
Coma
|
Coma
| 1
| 11
|
under $11k
| 44
| 63,687
| 39,086.125
| 42,579
| 23.5
|
black
| 14.5
| 16
| 0.855957
| 0.826904
| 3
| 0
| 0
|
no
| null | null |
dnr after sadm
| 34
| 100
| 11.599609
| 120
| 28
| 36.59375
| null | 2.699707
| 0.5
| 0.599976
| 141
| null | 61
| 17
| null | null | 0
|
<2 mo. follow-up
| 0
| 41
| 1
|
63.66599
|
male
| 0
| 32
|
Coma
|
Coma
| 1
| 14
| null | 44
| 56,792
| 36,616.5
| 39,677
| 20.25
|
black
| 19.796875
| 38
| 0.61792
| 0.554932
| 1
| 1
| 0
|
no
| 0.3
| 0.3
|
no dnr
| 32
| 38
| 71.890625
| 145
| 12
| 38.69531
| 104.28125
| 1.599854
| 0.299988
| 2.5
| 145
| 7.379883
| 85
| 28
| 1,110
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 415
| 1
|
59.29099
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 11
|
under $11k
| 0
| 4,828
| 3,260.1367
| 3,606
| 8
|
black
| 17.296875
| 24
| 0.907959
| 0.845947
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 6
| 132
| 11.298828
| 155
| 10
| 36.29688
| 147.5
| 1.5
| 3.799805
| 2.399902
| 133
| 7.359375
| 60
| 31
| 1,120
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 659
| 0
|
62.29199
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 5
| null | 0
| 8,323
| 6,026.5977
| 6,719
| 15.5
|
black
| 15.5
| 40
| 0.907959
| 0.843994
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 9
| 112
| 18.699219
| 95
| 26
| 38.39844
| 106.65625
| null | null | 3.099609
| 152
| 7.349609
| 362
| 86
| 1,790
| 1
| 4
|
no(M2 and SIP pres)
| 4
| 658
| 0
|
68.08197
|
female
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null |
under $11k
| 61
| 57,265
| 32,837.0625
| 35,035
| 35.5
|
black
| 28.5
| 58
| 0.257996
| 0.152985
| 12
| 0
| 0
|
yes
| 0.3
| 0.25
|
dnr before sadm
| -2
| 55
| 11.199219
| 75
| 40
| 36
| 189.78125
| 2.299805
| null | 1.5
| 135
| 7.489258
| 88
| 22
| 695
| null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
73.71399
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 80,540
| 43,399.2812
| 47,371
| 46
|
white
| 35.296875
| 60
| 0.398987
| 0.279968
| 3
| 0
| 0
|
yes
| 0.1
| 0
|
no dnr
| 7
| 69
| 5.599609
| 76
| 14
| 35.59375
| null | 2.899902
| 0.5
| 0.599976
| 133
| null | 90
| 4
| null | null | 5
|
<2 mo. follow-up
| 5
| 7
| 1
|
48.25497
|
male
| 0
| 13
|
Colon Cancer
|
Cancer
| 1
| 16
| null | 0
| 23,651
| 13,812.6797
| 12,455
| 11.5
|
white
| 29.398438
| 19
| 0.631958
| 0.320984
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.3
|
no dnr
| 13
| 48
| 8.298828
| 65
| 8
| 37.89844
| 247.5
| 2.399902
| null | 1.599854
| 138
| 7.459961
| 165
| 70
| 97.5
| 1
| 6
|
no(M2 and SIP pres)
| 6
| 395
| 1
|
37.20697
|
male
| 1
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 9
| null | 41
| 111,985
| null | null | 43
|
black
| 24.199219
| 31
| 0.780884
| 0.709961
| 2
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 15
| 74
| 7.899414
| 74
| 20
| 37.69531
| null | null | null | 0.599976
| 134
| null | 80
| 4
| null | null | 1
|
<2 mo. follow-up
| 1
| 15
| 1
|
83.29895
|
female
| 0
| 24
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 9
| 15,835
| 12,287.8438
| 12,138
| 5.666664
|
black
| 15.898438
| 23
| 0.833984
| 0.727905
| 1
| 0
| 1
|
no
| 0.8
| 0.6
|
no dnr
| 24
| 45
| 2.899902
| 125
| 26
| 38.09375
| 80
| 4.099609
| 25.296875
| 5.699219
| 146
| 7.239258
| 55
| 60
| 5
| null | 1
|
no(M2 and SIP pres)
| 1
| 146
| 1
|
70.95099
|
male
| 1
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 44
| 76,564
| 45,860.5312
| 47,719
| 29.25
|
white
| 29.898438
| 52
| 0.480957
| 0.362976
| 1
| 0
| 0
|
no
| 0.2
| 0.5
|
dnr after sadm
| 13
| 62
| 10.099609
| 195
| 12
| 38.39844
| 131.09375
| 1.5
| 1.899902
| 2
| 138
| 7.379883
| 112
| 54
| 1,217
| null | 0
|
<2 mo. follow-up
| 0
| 37
| 1
|
79.78595
|
female
| 1
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 10
| null | 0
| 6,594
| 4,640.9648
| 5,491
| 24.5
|
white
| 20.296875
| 37
| 0.80896
| 0.690918
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 8
| 115
| 13.099609
| 105
| 32
| 38.29688
| 284
| null | null | 0.699951
| 138
| 7.449219
| 94
| 6
| 3,020
| 0
| 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
55.59998
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
under $11k
| 9
| 36,284
| null | null | 26
|
white
| 14.798828
| 12
| 0.907959
| 0.875
| 1
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 11
| 128
| 14.099609
| 75
| 12
| 37.69531
| 188.5625
| 3
| 0.599976
| 0.599976
| 143
| 7.419922
| 181
| 22
| 2,640
| 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 655
| 0
|
39.23099
|
female
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 9
| 159,687
| 95,423.4375
| 87,275
| 43
|
white
| 33.09375
| 88
| 0.73291
| 0.650879
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 37
| 130
| 15.699219
| 55
| 40
| 37.5
| 371.375
| null | null | 1.5
| 137
| 7.429688
| 156
| 36
| 1,225
| null | 0
|
no(M2 and SIP pres)
| 0
| 655
| 0
|
35.32098
|
male
| 1
| 25
|
Coma
|
Coma
| 0
| 14
|
under $11k
| 55
| 192,755
| null | null | 34
|
black
| 23.699219
| 30
| 0.60498
| 0.540894
| 34
| 0
| 0
|
no
| 0.1
| 0
|
no dnr
| 25
| 153
| 13
| 110
| 24
| 35.09375
| 140.8125
| 3.899902
| null | 1.299805
| 136
| 7.40918
| 205
| 49
| 4,230
| null | 0
|
<2 mo. follow-up
| 0
| 25
| 1
|
66.81494
|
female
| 1
| 20
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
| null | 0
| 65,242
| 38,550.9375
| 37,962
| 24
|
white
| 27.097656
| 58
| 0.540894
| 0.425964
| 9
| 0
| 0
|
yes
| 0.5
| 0.5
|
dnr after sadm
| 16
| 105
| 8.199219
| 65
| 14
| 35.09375
| 385.6875
| null | 0.399963
| 1.899902
| 139
| 7.489258
| 231
| 52
| 1,950
| null | 3
|
<2 mo. follow-up
| 3
| 20
| 1
|
58.85797
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 9
| 47,752
| 30,081.6094
| 32,939
| 14.333328
|
black
| 24.398438
| 36
| 0.747925
| 0.668945
| 8
| 1
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 21
| 142
| 14.599609
| 135
| 10
| 38.69531
| 388
| null | 0.599976
| 0.699951
| 146
| 7.429688
| 108
| 5
| 3,100
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 90
| 1
|
47.65799
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
|
$11-$25k
| 0
| 26,875
| 15,939.4609
| 16,254
| 16
|
black
| 28.597656
| 59
| 0.785889
| 0.715942
| 2
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 12
| 118
| 5.199219
| 65
| 6
| 36.5
| 396
| 3.199707
| 0.5
| 0.699951
| 139
| 7.509766
| 132
| null | 2,675
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 652
| 0
|
68.87897
|
male
| 0
| 21
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 15,410
| 11,309.7656
| 11,194
| 6
|
white
| 16.097656
| 12
| 0.887939
| 0.813965
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 21
| 72
| 6.099609
| 105
| 14
| 36.19531
| 290
| null | 1.099854
| 1.199951
| 135
| 7.449219
| 117
| 20
| 5,460
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 652
| 0
|
71.92096
|
female
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 9
| 99,233
| 57,108.9688
| 59,108
| 34.5
|
white
| 21.398438
| 45
| 0.782959
| 0.712891
| 2
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 26
| 52
| 24
| 115
| 18
| 37.89844
| 98.32812
| 2
| null | 0.799927
| 133
| 7.399414
| 129
| 34
| 1,290
| null | 0
|
no(M2 and SIP pres)
| 0
| 652
| 0
|
77.18799
|
male
| 0
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 9
| 50,610
| 31,015.6094
| 32,517
| 19.75
|
black
| 19.699219
| 15
| 0.789917
| 0.721924
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 32
| 70
| 12.199219
| 116
| 20
| 36.69531
| null | null | null | 0.899902
| 139
| null | 71
| 15
| null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 90
| 1
|
52.22998
|
male
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
>$50k
| 0
| 48,448
| 27,241.3438
| 21,755
| 20.333328
|
white
| 22.796875
| 34
| 0.848999
| 0.795898
| 2
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 23
| 143
| 7.199219
| 55
| 22
| 36.29688
| 226.0625
| 3.799805
| 0.5
| 0.799927
| 144
| 7.399414
| 122
| 23
| null | 7
| 7
|
adl>=4 (>=5 if sur)
| 7
| 650
| 0
|
72.909
|
male
| 1
| 7
|
Coma
|
Coma
| 2
| 3
|
under $11k
| 100
| 53,008
| 30,680.5156
| 31,262
| 34.5
|
white
| 27.699219
| 63
| 0.028
| 0.012999
| 11
| 1
| 0
|
no
| 0.05
| 0.05
|
dnr after sadm
| 4
| 117
| 2.399902
| 165
| 53
| 39.69531
| 132.5
| 3.099609
| 0.5
| 1.199951
| 133
| 7.359375
| 157
| 10
| 4,550
| null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
72.96899
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
$11-$25k
| 0
| 28,292
| 17,936.1094
| 17,885
| 9
|
white
| 25.5
| 33
| 0.725952
| 0.640991
| 3
| 1
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 15
| 105
| 17.097656
| 120
| 30
| 39.19531
| 192.5
| 2.399902
| 2.399902
| 0.5
| 137
| 7.399414
| 97
| 7
| 6,869
| null | 1
|
no(M2 and SIP pres)
| 1
| 650
| 0
|
65.03796
|
male
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
$11-$25k
| 0
| 68,227
| 38,085.5312
| 41,467
| 35
|
white
| 24.796875
| 54
| 0.795898
| 0.727905
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
dnr after sadm
| 15
| 69
| 0.699951
| 108
| 24
| 38.39844
| null | null | null | 0.5
| 142
| null | 70
| 4
| null | null | 1
|
<2 mo. follow-up
| 1
| 17
| 1
|
53.36899
|
female
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 74,535
| 42,580.4375
| 41,409
| 25.25
|
black
| 29.699219
| 43
| 0.761963
| 0.685913
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 26
| 68
| 7
| 65
| 24
| 36.39844
| null | null | 0.5
| 0.799927
| 136
| null | 124
| 13
| 1,550
| null | null |
no(M2 and SIP pres)
| 2.134766
| 649
| 0
|
70.935
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 15
|
>$50k
| 9
| 9,011
| 5,791.9414
| 6,667
| 7.5
|
white
| 19.699219
| 30
| 0.819946
| 0.706909
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 4
| 112
| 23.796875
| 120
| 12
| 38.5
| 283.3125
| 2.599609
| 1.599854
| 3
| 145
| 7.259766
| 82
| 58
| 1,490
| 5
| 5
|
no(M2 and SIP pres)
| 5
| 649
| 0
|
74.86395
|
female
| 1
| 41
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
$25-$50k
| 0
| 293,806
| 168,017
| 171,702
| 36.25
|
white
| 26.898438
| 44
| 0.542969
| 0.428955
| 42
| 0
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 41
| 42
| 16.898438
| 145
| 45
| 38.59375
| 210
| null | 0.399963
| 7.5
| 139
| 7.419922
| 507
| 101
| 15
| null | 6
|
<2 mo. follow-up
| 6
| 41
| 1
|
71.64099
|
male
| 0
| 6
|
Coma
|
Coma
| 1
| 12
|
under $11k
| 100
| 6,228
| 4,059.707
| 4,164
| 9
|
white
| 20.199219
| 28
| 0.246979
| 0.181
| 1
| 0
| 1
|
no
| 0.7
| 0.5
|
dnr after sadm
| 1
| 57
| 14.099609
| 115
| 10
| 39.5
| 118.32812
| 2.299805
| 0.699951
| 0.699951
| 141
| 7.439453
| 281
| 20
| 3,545
| null | 7
|
<2 mo. follow-up
| 7
| 52
| 1
|
29.65599
|
male
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 17
|
$11-$25k
| 0
| 281,407
| 160,268.5
| 143,505
| 37.666657
|
black
| 37.59375
| 64
| 0.619995
| 0.515991
| 40
| 0
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 16
| 68
| 16.398438
| 105
| 36
| 38.69531
| 110
| null | 0.5
| 0.799927
| 146
| 7.5
| 243
| 18
| 3,480
| null | 0
|
<2 mo. follow-up
| 0
| 17
| 1
|
51.73398
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 100
| 24,569
| 14,623.6016
| 15,029
| 52
|
white
| 43.296875
| 105
| 0.035995
| 0.009998
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 2
| 58
| 9.5
| 115
| 30
| 38.29688
| 202.84375
| 2.5
| 0.5
| 0.899902
| 149
| 7.399414
| 137
| 25
| 2,370
| null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
56.29797
|
male
| 0
| 64
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 227,291
| 151,162.875
| 154,709
| 46
|
white
| 41.695313
| 47
| 0.465942
| 0.346985
| 1
| 1
| 0
|
no
| 0.7
| 0.65
|
no dnr
| 64
| 101
| 6.799805
| 80
| 16
| 37.79688
| null | 3.899902
| 0.199982
| 1.099854
| 142
| null | 175
| 11
| null | null | 1
|
SIP>=30
| 1
| 646
| 0
|
49.26199
|
male
| 0
| 13
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 10
|
under $11k
| 0
| 15,670
| 10,045.3906
| 13,425
| 5
|
white
| 21.097656
| 48
| 0.830933
| 0.723999
| 1
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 13
| 62
| 15.599609
| 35
| 33
| 35
| 190
| 2.599609
| null | 2.699707
| 138
| 7.369141
| 224
| 134
| 240
| 5
| 3
|
SIP>=30
| 3
| 175
| 1
|
61.46698
|
male
| 1
| 9
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 13,209
| 7,907.5664
| 8,379
| 7
|
white
| 12.599609
| 12
| 0.791992
| 0.559937
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
dnr after sadm
| 9
| 75
| 6.799805
| 67
| 20
| 36.19531
| null | 3.599609
| 0.399963
| 1
| 140
| null | 98
| 13
| 5,700
| 0
| 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
92.73096
|
female
| 0
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
$11-$25k
| 26
| 91,653
| 56,649.7812
| 61,899
| 20
|
black
| 22.199219
| 23
| 0.438965
| 0.31897
| 19
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 19
| 65
| 10.298828
| 115
| 27
| 39.09375
| 146
| 2.799805
| 0.199982
| 0.399963
| 137
| 7.439453
| 139
| 11
| 2,174
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 461
| 1
|
60.63797
|
female
| 1
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 145,919
| null | null | 32.25
|
white
| 16.796875
| 23
| 0.895996
| 0.858887
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
dnr after sadm
| 20
| 142
| 10.699219
| 72
| 26
| 38
| 246.65625
| null | null | 10.599609
| 136
| 7.429688
| 84
| 52
| 615
| 0
| 1
|
<2 mo. follow-up
| 1
| 26
| 1
|
56.59399
|
female
| 0
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 16
| null | 0
| 21,295
| 12,869.1562
| 13,625
| 16
|
black
| 31.199219
| 47
| 0.428955
| 0.309998
| 2
| 0
| 0
|
metastatic
| null | null |
no dnr
| 9
| 68
| 9.398438
| 102
| 16
| 36.39844
| null | 3.399902
| 0.399963
| 0.5
| 141
| null | 88
| 5
| 7,455
| 1
| 0
|
adl>=4 (>=5 if sur)
| 0
| 128
| 1
|
63.02298
|
female
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 13
|
$25-$50k
| 0
| 21,498
| 13,531.0625
| 12,646
| 20.333328
|
white
| 17.398438
| 27
| 0.890991
| 0.816895
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 16
| 68
| 10
| 110
| 29
| 37.79688
| 270
| 2.299805
| 0.399963
| 1.599854
| 154
| 7.339844
| 119
| 38
| 2,795
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 643
| 0
|
60.90097
|
female
| 1
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 7
| null | 9
| 99,519
| null | null | 39
|
white
| 44.09375
| 82
| 0.204987
| 0.110992
| 2
| 0
| 0
|
yes
| 0.5
| 0.25
|
dnr after sadm
| 12
| 62
| 2.799805
| 175
| 20
| 37.89844
| 133.3125
| 2.599609
| 1.199951
| 2.199707
| 140
| 7.40918
| 185
| 54
| 4,155
| null | 6
|
<2 mo. follow-up
| 6
| 19
| 1
|
63.92099
|
female
| 0
| 3
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
| null | 0
| 3,315
| 2,266.6445
| 2,414
| 12
|
white
| 22.199219
| 37
| 0.807983
| 0.689941
| 1
| 0
| 0
|
yes
| 0.5
| 0.25
|
no dnr
| 3
| 65
| 3.399902
| 105
| 36
| 37.89844
| 126.51562
| null | 1
| 2.299805
| 132
| 7.369141
| 107
| 37
| 2,325
| null | null |
no(M2 and SIP pres)
| 2.53418
| 353
| 1
|
55.85999
|
female
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 37
| 79,183
| null | null | 30.25
|
white
| 23.097656
| 53
| 0.753906
| 0.675903
| 1
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 25
| 70
| 6.599609
| 65
| 30
| 35
| 223.3125
| 2.899902
| null | 1.399902
| 136
| 7.40918
| 92
| 34
| 2,530
| null | 0
|
no(M2 and SIP pres)
| 0
| 642
| 0
|
54.021
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 2
| 11
|
$11-$25k
| 0
| null | 1,357.7764
| 1,846
| 5
|
white
| 30.796875
| 17
| 0.386963
| 0.094986
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 3
| 78
| 2.5
| 105
| 20
| 36
| 214.28125
| 1.599854
| 1.899902
| 1.399902
| 142
| 7.40918
| 132
| 40
| 200
| 2
| 2
|
no(M2 and SIP pres)
| 2
| 536
| 1
|
64.49799
|
male
| 0
| 49
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 41
| 148,554
| 83,934.25
| 96,493
| 30.25
|
white
| 32.898438
| 43
| 0.392944
| 0.273987
| 4
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 49
| 72
| 18.398438
| 85
| 19
| 36.39844
| 180
| 2.599609
| null | 1.5
| 134
| 7.429688
| 166
| 39
| 5,778
| null | 0
|
no(M2 and SIP pres)
| 0
| 641
| 0
|
60.86798
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 4
|
under $11k
| 0
| 9,822
| 6,247.3242
| 6,229
| 23
|
white
| 17.097656
| 18
| 0.897949
| 0.828979
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 6
| 100
| 20.296875
| 84
| 20
| 37
| 498
| null | null | 0.899902
| 143
| 7.279297
| 102
| 26
| 2,660
| 2
| null |
adl>=4 (>=5 if sur)
| 1.838867
| 641
| 0
|
55.17899
|
male
| 0
| 106
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 26
| 573,218
| 320,278
| 339,372
| 37.75
|
black
| 25.898438
| 34
| 0.641968
| 0.540894
| 57
| 0
| 0
|
no
| null | null |
no dnr
| 106
| 35
| 13.398438
| 145
| 34
| 39
| 237.125
| null | null | 1.699951
| 146
| 7.389648
| 114
| 39
| 845
| null | 0
| null | 0
| 640
| 0
|
47.84399
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
| null | 100
| 34,109
| null | null | 33
|
other
| 21.398438
| 22
| 0.55188
| 0.438965
| 3
| 1
| 0
|
no
| 0
| 0
|
dnr after sadm
| 2
| 117
| 10
| 75
| 40
| 38.39844
| 260
| null | 11.599609
| 2.599609
| 141
| 7.479492
| 250
| 63
| 1,950
| null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
53.51099
|
female
| 0
| 18
|
Lung Cancer
|
Cancer
| 1
| 20
|
>$50k
| 0
| 36,304
| 21,369.9688
| 19,303
| 11.666664
|
white
| 15
| 13
| 0.767944
| 0.519897
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 18
| 115
| 15.898438
| 125
| 45
| 38.5
| 233.3125
| 2.599609
| null | 0.699951
| 137
| 7.439453
| 132
| 6
| 3,555
| 2
| null |
adl>=4 (>=5 if sur)
| 1.838867
| 88
| 1
|
78.64795
|
female
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
| null | 0
| 43,537
| 25,966.8438
| 29,665
| 11
|
white
| 14.699219
| 16
| 0.8479
| 0.795898
| 6
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 6
| 38
| 3.599609
| 130
| 8
| 34.79688
| 152
| 2
| 0.699951
| 2.099609
| 130
| 7.429688
| 33
| 24
| 3,280
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 637
| 0
|
41.11697
|
female
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
under $11k
| 9
| 113,278
| 66,799.8125
| 68,660
| 27
|
black
| 16.5
| 24
| 0.890991
| 0.851929
| 16
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 27
| 126
| 4.199219
| 70
| 26
| 38.09375
| 371.375
| null | null | 1.299805
| 137
| 7.369141
| 87
| 7
| 2,800
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 637
| 0
|
79.37897
|
male
| 0
| 17
|
Coma
|
Coma
| 0
| null | null | 41
| 169,122
| 99,286.75
| 100,516
| 33.666657
|
white
| 16.597656
| 28
| 0.440979
| 0.366943
| 41
| 0
| 0
|
no
| null | null |
no dnr
| 17
| 136
| 7.099609
| 45
| 12
| 38
| 286.625
| 2.799805
| null | 2
| 137
| 7.389648
| 288
| 31
| 1,715
| null | null | null | 1.862061
| 637
| 0
|
55.61899
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 8
| null | 41
| 32,806
| null | null | 12.666664
|
white
| 17.296875
| 14
| 0.762939
| 0.68689
| 3
| 1
| 0
|
yes
| 0.75
| 0.6
|
no dnr
| 17
| 120
| 5.299805
| 60
| 26
| 36.19531
| 276
| null | 0.399963
| 1
| 144
| 7.379883
| 194
| 18
| 2,250
| null | 1
|
no(M2 and SIP pres)
| 1
| 637
| 0
|
30.40099
|
female
| 0
| 113
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 461,600
| null | null | 43.25
|
black
| 30.097656
| 40
| 0.834961
| 0.778931
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 113
| 132
| 4.5
| 68
| 24
| 38.09375
| 219.03125
| null | 0.599976
| 1.799805
| 139
| 7.369141
| 229
| 33
| 4,150
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 635
| 0
|
64.797
|
male
| 0
| 63
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
$25-$50k
| 0
| 286,996
| 162,759.125
| 158,849
| 43.5
|
white
| 26
| 44
| 0.706909
| 0.61792
| 16
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 63
| 72
| 17.199219
| 125
| 25
| 36.5
| 330
| 1.899902
| 2.899902
| 1.799805
| 149
| 7.419922
| 108
| 30
| 1,550
| null | 0
|
SIP>=30
| 0
| 635
| 0
|
86.91595
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 9
| 96,288
| 59,030.1875
| 58,776
| 18.333328
|
white
| 23.296875
| 30
| 0.599976
| 0.492981
| 36
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 68
| 22.597656
| 95
| 14
| 36.09375
| 116.65625
| null | 1.5
| 5.399414
| 130
| 7.429688
| 156
| 75
| 43
| null | 0
|
<2 mo. follow-up
| 0
| 53
| 1
|
80.323
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
| null | 0
| 24,828
| null | null | 22
|
white
| 20.5
| 36
| 0.72998
| 0.646973
| 3
| 0
| 0
|
yes
| 1
| 0.6
|
no dnr
| 9
| 103
| 3.599609
| 75
| 20
| 36.79688
| null | 2.299805
| 1.399902
| 1.599854
| 137
| null | 109
| 4
| null | null | 0
| null | 0
| 634
| 0
|
27.26099
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 22,451
| null | null | 19
|
black
| 31.5
| 59
| 0.827881
| 0.768921
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 9
| 118
| 15.298828
| 55
| 34
| 38.79688
| 220
| 2.399902
| 4.099609
| 0.799927
| 152
| 7.389648
| 102
| 13
| 4,770
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 633
| 0
|
46.47998
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 9
|
under $11k
| 0
| 36,739
| null | null | 38
|
black
| 35.59375
| 52
| 0.680908
| 0.586914
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 5
| 77
| 8.298828
| 60
| 26
| 37.59375
| 257.125
| null | 1.099854
| 1.199951
| 141
| 7.519531
| 111
| 10
| 2,025
| null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
65.94397
|
female
| 1
| 18
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 4
|
under $11k
| 100
| 26,626
| null | null | 16
|
black
| 25.097656
| 49
| 0.167999
| 0.043999
| 1
| 1
| 0
|
no
| 0.2
| 0.05
|
dnr after sadm
| 18
| 67
| 10.298828
| 55
| 35
| 38.59375
| 212.5
| null | 5
| 3.699707
| 136
| 7.469727
| 286
| 82
| 4,600
| null | 4
|
<2 mo. follow-up
| 4
| 18
| 1
|
70.75397
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
$11-$25k
| 9
| 27,012
| 16,491.5312
| 17,150
| 22.5
|
white
| 19.597656
| 31
| 0.813965
| 0.751953
| 2
| 1
| 0
|
no
| 0.6
| 0.4
|
no dnr
| 13
| 60
| 9.798828
| 55
| 24
| 35.79688
| 309.5
| 4
| 1.099854
| 1.899902
| 150
| 7.449219
| 70
| 53
| 1,475
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 631
| 0
|
73.10596
|
female
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
$25-$50k
| 44
| 174,244
| null | null | 36
|
white
| 35.796875
| 63
| 0.173981
| 0.088989
| 22
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 22
| 103
| 14
| 75
| 24
| 38.79688
| 281
| null | 0.699951
| 1.199951
| 137
| 7.439453
| 88
| 13
| 1,240
| null | 6
|
Coma or Intub
| 6
| 632
| 0
|
56.89499
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 18,632
| null | null | 20
|
black
| 23.097656
| 45
| 0.852905
| 0.756958
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 8
| 62
| 26.898438
| 75
| 36
| 35.79688
| 115.70312
| 2.299805
| 0.899902
| 5
| 137
| 7.329102
| 148
| 69
| 66
| null | null | null | 2.893066
| 632
| 0
|
52.79099
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 12,395
| 4,226.0586
| 4,189
| 7.5
|
white
| 16.097656
| 9
| 0.919922
| 0.86499
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 8
| 120
| 14.5
| 105
| 11
| 38.5
| 316.625
| null | 2.5
| 2.099609
| 148
| 7.419922
| 60
| 34
| 2,510
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 632
| 0
|
75.87994
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 11
|
under $11k
| 9
| 17,026
| null | null | 18
|
white
| 29.097656
| 40
| 0.637939
| 0.45697
| 1
| 0
| 0
|
no
| 0.4
| 0.3
|
dnr after sadm
| 2
| 125
| 25.699219
| 125
| 32
| 37.69531
| 246.65625
| null | null | 2.599609
| 141
| 7.399414
| 249
| 70
| 1,155
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 225
| 1
|
60.66498
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 7
|
under $11k
| 0
| 14,779
| null | null | 19.5
|
white
| 20.398438
| 43
| 0.869995
| 0.783936
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 7
| 117
| 12.398438
| 112
| 24
| 38.19531
| 210.1875
| 1.399902
| 4.899414
| 1.099854
| 132
| 7.299805
| 174
| 19
| 3,575
| 3
| 1
|
no(M2 and SIP pres)
| 1
| 631
| 0
|
69.64496
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
|
>$50k
| 0
| 79,048
| 46,799.625
| 45,539
| 23
|
white
| 24.597656
| 42
| 0.704956
| 0.615967
| 22
| 0
| 0
|
no
| 0.1
| 0.5
|
dnr after sadm
| 3
| 160
| 43.195313
| 125
| 28
| 37.69531
| 280
| 2.199707
| 1.099854
| 2.5
| 151
| 7.369141
| 202
| 59
| 2,110
| null | 0
|
<2 mo. follow-up
| 0
| 49
| 1
|
53.06998
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 6,650
| null | null | 9
|
white
| 14.398438
| 9
| 0.779907
| 0.539917
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 4
| 103
| 5.5
| 80
| 20
| 36.19531
| null | null | null | 1.5
| 138
| null | 148
| 17
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 202
| 1
|
82.54297
|
male
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 13
|
$11-$25k
| 0
| 14,698
| null | null | 9.333328
|
white
| 21.597656
| 8
| 0.611938
| 0.424988
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.25
|
dnr after sadm
| 5
| 58
| 16.796875
| 65
| 8
| 38.29688
| 172
| null | null | 1.5
| 144
| 7.349609
| 292
| 32
| 7,315
| 2
| 1
|
<2 mo. follow-up
| 1
| 15
| 1
|
68.383
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
| null | 0
| 35,772
| null | null | 25.5
|
white
| 23.597656
| 38
| 0.787964
| 0.717896
| 2
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 10
| 93
| 8.898438
| 65
| 28
| 39.5
| 185
| null | null | 0.699951
| 137
| 7.369141
| 149
| 14
| 1,595
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 628
| 0
|
85.74396
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 5,616
| 3,942.7949
| 4,634
| 4
|
white
| 17.898438
| 22
| 0.777954
| 0.645996
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 7
| 122
| 13.898438
| 120
| 29
| 36.59375
| 250
| 2.099609
| 0.199982
| 0.899902
| 133
| 7.359375
| 81
| 8
| 3,965
| 3
| null | null | 2.510742
| 263
| 1
|
68.02496
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 5
|
under $11k
| 9
| 3,742
| 2,707.2363
| 2,761
| 8
|
black
| 31.5
| 45
| 0.630981
| 0.447998
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 52
| 13.898438
| 60
| 11
| 39.5
| 205.6875
| 2.799805
| 0.299988
| 2.599609
| 142
| 7.239258
| 527
| 44
| 360
| null | 2
|
adl>=4 (>=5 if sur)
| 2
| 154
| 1
|
49.93298
|
male
| 0
| 18
|
Colon Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 27,935
| null | null | 17
|
white
| 19.898438
| 25
| 0.805908
| 0.585938
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 18
| 70
| 5.299805
| 105
| 33
| 38.19531
| 205
| null | null | 1.199951
| 127
| 7.379883
| 234
| 21
| 960
| null | 0
|
<2 mo. follow-up
| 0
| 50
| 1
|
20.48199
|
male
| 0
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
| null | 0
| 200,937
| 114,746.375
| 112,610
| 36.75
|
white
| 28
| 64
| 0.85498
| 0.803955
| 6
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 35
| 58
| 13.699219
| 115
| 38
| 38.19531
| 213.3125
| null | 0.799927
| 1.399902
| 148
| 7.339844
| 100
| 55
| 1,375
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 627
| 0
|
87.92596
|
female
| 0
| 49
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 15
|
$11-$25k
| 9
| 50,071
| 33,320.0312
| 35,008
| 16.75
|
white
| 20.898438
| 24
| 0.67395
| 0.50293
| 1
| 0
| 1
|
no
| null | null |
dnr after sadm
| 3
| 120
| 16.199219
| 125
| 42
| 37.69531
| 170
| 2.399902
| 0.5
| 0.5
| 132
| 7.449219
| 113
| 13
| 5,325
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 465
| 1
|
34.995
|
male
| 0
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
>$50k
| 0
| 19,106
| 11,641.5312
| 12,083
| 11
|
white
| 23.597656
| 42
| 0.665894
| 0.569946
| 2
| 0
| 0
|
metastatic
| 0.95
| 0.85
|
no dnr
| 10
| 101
| 26.796875
| 136
| 24
| 36.69531
| 348
| 3.799805
| 0.299988
| 0.899902
| 140
| 7.389648
| 220
| 22
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 626
| 0
|
76.047
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 16
|
>$50k
| 0
| 5,420
| null | null | 9
|
white
| 14.798828
| 20
| 0.868896
| 0.782959
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 52
| 21.597656
| 70
| 12
| 38.09375
| 134
| 2.599609
| 0.799927
| 1.299805
| 149
| 7.379883
| 147
| 46
| 910
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 626
| 0
|
46.99197
|
female
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 109,299
| 55,014.5938
| 59,859
| 38.666657
|
other
| 22.199219
| 19
| 0.837891
| 0.782959
| 12
| 0
| 0
|
no
| null | null |
dnr before sadm
| -2
| 145
| 20.296875
| 56
| 22
| 36
| null | null | 1
| 1.299805
| 143
| null | 121
| 32
| 1,425
| null | 7
|
<2 mo. follow-up
| 7
| 14
| 1
|
40.47897
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$11-$25k
| 0
| 9,844
| 6,419.6797
| 6,699
| 6
|
black
| 14
| 18
| 0.942993
| 0.921997
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 115
| 27.796875
| 115
| 20
| 35.69531
| 176.65625
| null | 3.099609
| 3
| 129
| 7.449219
| 380
| 70
| 975
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 624
| 0
|
62.07797
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 6
|
under $11k
| 0
| 6,699
| 4,312.0977
| 4,687
| 15
|
black
| 19.097656
| 31
| 0.884888
| 0.807983
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 58
| 31.398438
| 145
| 34
| 35.29688
| 91.42188
| null | null | 2.799805
| 150
| 7.429688
| 53
| 41
| 350
| 1
| null |
no(M2 and SIP pres)
| 1.166748
| 624
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.